HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin Duncan Selected Research

olokizumab

9/2014Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin Duncan Research Topics

Disease

3Rheumatoid Arthritis
11/2015 - 09/2014
3Seizures (Absence Seizure)
10/2013 - 05/2009
2Epilepsy (Aura)
10/2013 - 10/2010
1Necrosis
09/2014
1Sleepiness
05/2009
1Connective Tissue Diseases (Connective Tissue Disease)
02/2004
1Congenital Heart Defects (Congenital Heart Defect)
02/2004
1Pulmonary Arterial Hypertension
02/2004

Drug/Important Bio-Agent (IBA)

3Levetiracetam (Keppra)FDA LinkGeneric
10/2013 - 05/2009
2Certolizumab PegolFDA Link
11/2015 - 11/2015
2Anticonvulsants (Antiepileptic Drugs)IBA
10/2010 - 05/2009
1Methotrexate (Mexate)FDA LinkGeneric
11/2015
1olokizumabIBA
09/2014
1Tumor Necrosis Factor InhibitorsIBA
09/2014
1Monoclonal AntibodiesIBA
09/2014
1Carbamazepine (Tegretol)FDA LinkGeneric
10/2013
1Valproic Acid (Depakote)FDA LinkGeneric
10/2013
1sitaxsentanIBA
02/2004
1Vasoconstrictor AgentsIBA
02/2004
1Vasodilator Agents (Vasodilators)IBA
02/2004
1Endothelins (Endothelin)IBA
02/2004
1Endothelin B ReceptorIBA
02/2004

Therapy/Procedure

3Therapeutics
09/2014 - 02/2004
1Time-to-Treatment
10/2013